Related by context. All words. (Click for frequent words.) 71 docetaxel 69 fluoropyrimidine 69 Irinotecan 67 taxanes 67 topotecan 66 paclitaxel 66 erlotinib 66 HER2 positive metastatic breast 66 gemcitabine 66 antimetabolite 66 gemcitabine chemotherapy 66 trabectedin 65 bevacizumab 65 paclitaxel Taxol 65 Talabostat 65 5 fluorouracil 65 pegylated liposomal doxorubicin 65 Bortezomib 65 docetaxel Taxotere R 65 AEG# 65 chemotherapeutic drug 65 5 FU 65 vinca alkaloid 65 docetaxel chemotherapy 65 amrubicin 65 Paclitaxel 65 Erlotinib 65 docetaxel Taxotere ® 65 carboplatin paclitaxel 65 YONDELIS 65 liposomal formulation 65 Amrubicin 65 OncoVEX GM CSF 65 platinum refractory 64 MGCD# [001] 64 metaglidasen 64 pomalidomide 64 paclitaxel Taxol ® 64 Fludara 64 HGS ETR1 64 talabostat 64 sorafenib Nexavar 64 Herceptin trastuzumab 64 calcineurin inhibitors 64 regorafenib 64 Platinol 64 epothilone 64 Pemetrexed 64 taxane chemotherapy 64 alkylating agent 64 paclitaxel Taxol R 64 bevacizumab Avastin 64 gemcitabine Gemzar 64 idarubicin 64 microtubule inhibitor 64 chemotherapeutic agent 64 vinorelbine 64 immunotherapeutic agent 64 Taxol ® 64 Targretin 64 T DM1 64 Gemzar ® 64 cisplatin 64 relapsed ovarian cancer 63 Nexavar ® 63 mycophenolate mofetil 63 dasatinib 63 lapatinib Tykerb 63 gemcitabine carboplatin 63 oxaliplatin 63 paclitaxel carboplatin 63 cytotoxic 63 bevacizumab Avastin ® 63 Hycamtin 63 dacarbazine 63 Cytoxan 63 Doxil 63 chemotherapeutics 63 Panzem R NCD 63 NXL# 63 pertuzumab 63 bortezomib 63 Taxotere ® 63 orally bioavailable 63 tyrosine kinase inhibitor 63 docetaxel Taxotere 63 xanthine oxidase inhibitor 63 anticancer agents 63 gefitinib 63 sunitinib 63 PSMA ADC 63 receptor tyrosine kinase inhibitor 63 mRCC 63 Allovectin 7 ® 63 leucovorin 63 trastuzumab 63 BAY #-# 63 HuLuc# 63 DOXIL 63 resistant ovarian cancer 63 AP# [003] 63 metastatic renal cell carcinoma 63 chemotherapeutic 63 Gefitinib 63 relapsed multiple myeloma 63 enzastaurin 62 chemotherapy regimens 62 seliciclib 62 Trastuzumab 62 bendamustine 62 irinotecan 62 paclitaxel chemotherapy 62 gemcitabine cisplatin 62 trans retinoic acid ATRA 62 goserelin 62 OXi# 62 Omacetaxine 62 IMGN# 62 entinostat 62 decitabine 62 nucleoside analogs 62 protease inhibitor PI 62 refractory multiple myeloma 62 5-FU/LV 62 standard chemotherapy regimen 62 cetuximab 62 trastuzumab Herceptin ® 62 Taxotere 62 sorafenib Nexavar ® 62 remission induction 62 pemetrexed 62 cytotoxic chemotherapy 62 beta lactam 62 erlotinib Tarceva ® 62 carboplatin 62 Satraplatin 62 thalidomide Thalomid 62 MEK inhibitors 62 chemotherapy cisplatin 62 tyrosine kinase inhibitors 62 Amigal 62 panitumumab 62 metastatic colorectal cancer 62 LY# [003] 62 nucleoside analogue 62 metastatic CRC 62 interferon alfa 62 Velcade bortezomib 62 MGd 62 elotuzumab 62 oral antidiabetic 62 Seliciclib 62 farletuzumab 62 alvespimycin 62 CoFactor 62 HGS# 62 Bevacizumab 62 proteasome inhibitors 62 Dasatinib 62 imatinib Gleevec 62 Reverset 62 mTOR inhibitors 62 fluorouracil 62 Cloretazine 62 proteasome inhibitor 62 angiogenesis inhibitor 62 Temsirolimus 62 JAK inhibitors 62 aflibercept 62 Vidofludimus 61 Tarceva TM 61 SERMs 61 FOLFIRI 61 ixabepilone 61 IMC A# 61 estramustine 61 MNTX 61 Fludarabine 61 erlotinib Tarceva 61 MAGE A3 ASCI 61 posaconazole 61 nab paclitaxel 61 dasatinib Sprycel 61 pegfilgrastim 61 epothilones 61 cytarabine 61 HuMax CD4 61 CHOP chemotherapy 61 Aflibercept 61 chemotherapeutic agents 61 sevelamer 61 retinoid 61 daunorubicin 61 iniparib 61 temsirolimus 61 Doxil ® 61 cytotoxics 61 Dapagliflozin 61 Gemcitabine 61 INCB# [001] 61 Trabectedin 61 taxane therapy 61 Taxol paclitaxel 61 Hycamtin ® 61 nilotinib 61 PRT# 61 cetuximab Erbitux ® 61 ganetespib 61 imatinib mesylate 61 amphotericin B 61 PXD# 61 SCCHN 61 Fludara ® 61 chemotherapeutic regimen 61 Torisel 61 obatoclax 61 TREANDA 61 IMiDs 61 Xcytrin 61 polymerase inhibitor 61 Amplimexon 61 tyrosine kinase inhibitor TKI 61 CA4P 61 IRESSA 61 Taxotere docetaxel 61 mapatumumab 61 DAVANAT R 61 Tamibarotene 61 biologic therapy 61 5FU 61 forodesine 61 nucleoside reverse transcriptase inhibitor 61 CANCIDAS 61 PDE4 inhibitor 61 Onconase 61 follicular NHL 61 CCR5 antagonist 61 capecitabine 61 anthracycline 61 Perifosine 61 trastuzumab DM1 T DM1 61 EGFR TKI 61 IMiDs R 61 palifosfamide 61 IMiDs ® 61 sapacitabine 61 quinolone 61 ganciclovir 61 CYC# 61 Carboplatin 61 TriRima 61 mitomycin 61 infusional 5-FU/LV 61 cyclophosphamide methotrexate 61 milatuzumab 61 IMiDs ® compound 61 antithrombotic 61 sorafenib 61 cytotoxic therapy 60 hormone refractory prostate cancer 60 Voreloxin 60 Zolinza 60 picoplatin 60 Cisplatin 60 Aplidin 60 sorafenib tablets 60 Ozarelix 60 pegylated interferon alpha 60 Platinol ® cisplatin 60 Paraplatin ® 60 arsenic trioxide 60 perifosine 60 Chemophase 60 alpha interferon 60 Pertuzumab 60 valopicitabine 60 lapatinib 60 CAELYX 60 velafermin 60 PARP inhibitor 60 gefitinib Iressa 60 cilengitide 60 NRTIs 60 Ceflatonin 60 Maribavir 60 JAK inhibitor 60 Xanafide 60 Alkeran 60 KNS # 60 evaluating tivozanib 60 sunitinib malate 60 anti leukemic 60 bortezomib Velcade 60 axitinib 60 antibody fragment 60 superficial bladder cancer 60 NNRTIs 60 systemic antifungal 60 refractory ovarian cancer 60 panitumumab Vectibix 60 cisplatin chemotherapy 60 nucleoside 60 Pazopanib 60 nucleoside analog 60 TG# [003] 60 anticancer therapies 60 IAP inhibitors 60 ProLindac 60 mTOR inhibitor 60 Azilect ® 60 Taxotere R 60 molecularly targeted 60 talactoferrin 60 Ixempra 60 adecatumumab 60 lenalidomide Revlimid R 60 Lenocta 60 pharmacologically active isomer 60 Doxorubicin 60 imatinib Gleevec ® 60 vandetanib 60 HGS ETR2 60 Jevtana 60 eniluracil 60 Tyrima 60 phosphate binder 60 AKT inhibitor 60 PI3K/Akt pathway inhibitor 60 ENMD # 60 5 FU leucovorin 60 Rituxan rituximab 60 Nanobody 60 HSP# inhibitor 60 histone deacetylase HDAC inhibitor 60 XELOX 60 rituximab 60 GW# [003] 60 ISENTRESS 60 chlorambucil 60 HuMax EGFr 60 ONTAK 60 anti TNF 60 immunosuppressant 60 Alocrest 60 complete cytogenetic response 60 humanized antibody 60 Abraxane 60 Cloretazine ® 60 VIDAZA 60 mitoxantrone 60 octreotide 60 FOLFOX4 60 Elotuzumab 60 Traficet EN 60 ritonavir boosted protease inhibitor 60 Bezielle 60 insulin sensitizers 60 OvaRex ® MAb 60 Proxinium TM 60 interferon 60 Leukine ® 60 novel immunomodulatory 60 NNRTI 60 TAXOTERE R 60 melphalan prednisone 60 advanced NSCLC 60 sodium glucose cotransporter 60 humanized monoclonal antibody 60 hormone LHRH antagonist 60 Tarceva erlotinib 60 chimeric monoclonal antibody 60 glufosfamide 60 Interferon alfa 60 T#I mutation 60 letrozole Femara 60 interferon alpha 60 cediranib 59 lumiliximab 59 vinca alkaloids 59 antifolate 59 dexamethasone Decadron 59 trastuzumab emtansine T DM1 59 custirsen 59 Imprime PGG 59 indolent NHL 59 CD# antibody [001] 59 Gliadel Wafer 59 fludarabine phosphate 59 temozolomide 59 tesetaxel 59 doxorubicin 59 Capecitabine 59 anticancer agent 59 MGCD# [002] 59 cytostatic 59 Oxaliplatin 59 SPRYCEL ® 59 cytotoxic agents 59 BEXXAR 59 TBC# 59 Epirubicin 59 CBLC# 59 Gleevec resistant 59 TKIs 59 TELINTRA 59 Exemestane 59 Tarvacin 59 anti TNF alpha 59 refractory NSCLC 59 LEP ETU 59 daptomycin 59 EndoTAGTM 1 59 capecitabine Xeloda 59 metastatic breast cancer 59 imetelstat 59 FOLFOX 59 Tesmilifene 59 small molecule tyrosine 59 Rituximab 59 temozolomide TMZ 59 azacytidine 59 abiraterone acetate 59 tenofovir emtricitabine 59 investigational humanized monoclonal antibody 59 nucleoside reverse transcriptase inhibitors 59 oral prodrug 59 OPAXIO 59 mertansine 59 deforolimus 59 HER2 antibody 59 luteinizing hormone releasing 59 Lapatinib 59 epirubicin 59 chemotherapy docetaxel 59 Peg IFN 59 vascular disrupting agent 59 daclizumab 59 NP2 59 Oncaspar 59 cytarabine daunorubicin 59 Treanda 59 aflibercept VEGF Trap 59 HCV protease inhibitors 59 rituximab Rituxan 59 pegylated 59 PEG SN# 59 depsipeptide 59 carfilzomib 59 CCX# 59 chemically modified siRNA 59 pan HDAC inhibitor 59 DFMO 59 DAVANAT 59 heavily pretreated patients 59 oral antiviral 59 Nexavar sorafenib 59 cyclophosphamide Cytoxan 59 Faslodex 59 cabazitaxel 59 Lenalidomide 59 neratinib 59 recurrent ovarian cancer 59 TAFA# 59 Marqibo 59 atacicept 59 Xeloda ® 59 TACE 59 vidofludimus 59 azathioprine 59 Cremophor 59 metastatic malignant melanoma 59 INTELENCE 59 Pralatrexate 59 taxotere 59 non nucleoside reverse 59 chemotherapies 59 cisplatin gemcitabine 59 novel anticancer 59 Halaven 59 DACH platinum 59 ABRAXANE ® 59 piperacillin tazobactam 59 Allovectin 7 59 TNF alpha inhibitor 59 anti EGFR antibody 59 transcriptase inhibitor NNRTI 59 doxorubicin cyclophosphamide 59 PROCHYMAL 59 vorinostat 59 imatinib 59 pegylated interferon alfa 59 5 Fluorouracil 59 multi kinase inhibitor 59 Luteinizing Hormone Releasing Hormone 59 Troxatyl 59 EGFR TKIs 59 non squamous NSCLC 59 satraplatin 59 pralatrexate 59 TEMODAL 59 Docetaxel 59 nucleoside analogues 59 Annamycin 59 Hsp# Inhibitor 59 ibandronate 59 PKC# 59 abacavir lamivudine 59 Erbitux cetuximab 59 KRN# 59 refractory AML 59 Tesetaxel 59 ceftazidime 59 cyclophosphamide 59 trastuzumab Herceptin 59 EGFR tyrosine kinase inhibitors 59 Fluorouracil 59 VEGF inhibitors 59 enfuvirtide 59 bleomycin 59 disease modifying 59 metastatic hormone refractory 59 HRPC 59 tiotropium bromide 59 Mipomersen 59 TORISEL 59 pegylated interferons 59 protease inhibitor 59 Topotecan 59 Axitinib 59 T#I [002] 59 CIMZIA ™ 59 AEGR 59 Temozolomide 59 oblimersen 59 Pathway Inhibitor 59 PREZISTA r 59 antihypertensive agents 59 anticancer compound 59 protein kinase inhibitor 59 boosted protease inhibitor 59 generation Hsp# inhibitor 59 BCR ABL inhibitor 59 methylnaltrexone 59 taxane refractory 59 Etoposide 59 Dalbavancin 59 trastuzumab Herceptin R 59 IMiD 59 anthracyclines 59 acute GvHD 59 kinase inhibitors 59 dacarbazine DTIC 59 IL# PE#QQR 58 PEG Interferon lambda 58 liposomal doxorubicin 58 carboplatin chemotherapy 58 Civacir 58 standard chemotherapy regimens 58 OncoVEX 58 EOquin 58 huC# DM4 58 durable remissions 58 Copegus ribavirin 58 trastuzumab DM1 58 Kahalalide F 58 incyclinide 58 Navelbine 58 visilizumab 58 Quinamed 58 doublet chemotherapy 58 tolevamer 58 zidovudine AZT 58 Viramidine 58 EGFR inhibitors 58 clofarabine 58 heavily pretreated 58 Picoplatin 58 ZOLINZA 58 SAR# [004] 58 novel peptide 58 vemurafenib 58 tenofovir Viread 58 tigecycline 58 radiolabeled monoclonal antibody 58 MOZOBIL 58 dose cytarabine 58 metastatic RCC 58 topical antifungal 58 EFAPROXYN 58 Darusentan 58 clodronate 58 Pfizer Sutent 58 BMS # 58 granisetron 58 prostate cancer HRPC 58 Carfilzomib 58 Sanofi Aventis Taxotere 58 aminoglycoside 58 thiazolidinedione 58 PNP inhibitor 58 VAPRISOL 58 TLR9 agonist 58 MEK inhibitor 58 pegylated interferon alfa 2a 58 CCR5 inhibitor 58 plus dexamethasone 58 XYOTAX 58 refractory CTCL 58 RGB # 58 GRN#L 58 radezolid 58 recurrent NSCLC 58 tocilizumab 58 brostallicin 58 trabedersen 58 interferon beta 58 Paraplatin ® carboplatin 58 Ophena TM 58 assessing T DM1 58 indibulin 58 NRTI 58 solid tumors 58 BiTE 58 CR# vcMMAE 58 investigational compound 58 Panzem 58 OHR/AVR# 58 Rifampin 58 renin inhibitor 58 antiandrogen 58 nucleotide analogue 58 cisplatin carboplatin 58 Vectibix 58 CEQ# 58 Vicinium TM 58 chemoradiotherapy 58 Epivir HBV 58 flutamide 58 Glufosfamide 58 Camptosar 58 ceftriaxone 58 anthracycline taxane 58 ELOXATIN 58 ELACYT 58 IRX 2 58 cetuximab Erbitux 58 synthetic retinoid 58 vascular disrupting agents 58 acute leukemias 58 fondaparinux 58 bosutinib 58 TRISENOX ® 58 integrase inhibitor 58 cidofovir 58 PEGylated 58 targeted antifolate 58 vincristine 58 ZACTIMA 58 GAP #B# 58 Pimavanserin 58 SUTENT 58 adriamycin 58 cetuximab Erbitux R 58 Nexavar tablets 58 Vancomycin 58 evaluating T DM1 58 intravenous bisphosphonates 58 MyVax R 58 Gleevec imatinib 58 immunomodulatory 58 R#/MEM # 58 ADP receptor antagonist 58 Mylotarg 58 Hyphanox 58 azacitidine 58 tesmilifene 58 tinidazole 58 anthracycline chemotherapy 58 teriflunomide 58 TTF Therapy 58 YERVOY 58 antibody MAb 58 Phase Ib II 58 angiotensin receptor blocker ARB 58 ISTODAX 58 irbesartan 58 TNFerade 58 Linaclotide 58 oxidative stress inducer 58 HCV protease inhibitor 58 resminostat 58 vinorelbine tartrate 58 Gleevec imatinib mesylate 58 metastatic colorectal 58 alefacept 58 fludarabine 58 Platinol ® 58 imatinib mesylate Gleevec 58 PEP# [003] 58 OMP #M# 58 PSN# [002] 58 hematological cancers 58 uric acid lowering 58 thymalfasin 58 macrolide 58 rFVIII 58 Aurora kinase 58 novel histone deacetylase 58 DPP4 inhibitor 58 dasatinib Sprycel ® 58 Alpharadin 58 metformin sulfonylurea 58 multitargeted 58 adjuvant therapy 58 Vidaza azacitidine 58 Bruton tyrosine kinase Btk 58 CellCept 58 PDE4 inhibitors 58 alkylating agents 58 UVIDEM 58 plus gemcitabine 58 HCD# [002] 58 epithelial tumors 58 immunomodulator 58 iniparib BSI 58 Vandetanib 58 Insegia 58 antitumor activity 58 aromatase inhibitor 58 Xeloda capecitabine 58 tanespimycin 58 HQK 58 low dose cytarabine 58 somatostatin analogue 58 androgen independent 58 neoadjuvant chemotherapy 58 paclitaxel poliglumex 58 Camptosar ® irinotecan 58 raltegravir 58 INT# [002] 58 biologic DMARD 58 rifamycin 58 Abiraterone acetate 58 insulin sensitizing 58 HDACi 57 etoposide 57 therapeutic monoclonal antibody 57 Telintra 57 Symadex 57 advanced unresectable 57 nilotinib Tasigna 57 chemotherapeutic regimens 57 immunosuppressive regimens 57 anti VEGF 57 HGS ETR1 mapatumumab 57 lanthanum carbonate 57 DU #b 57 EOquin TM 57 oral antifungal 57 Pegasys peginterferon alfa 2a 57 efavirenz EFV 57 TYZEKA 57 albumin bound paclitaxel 57 tamibarotene 57 taxol 57 mCRC patients 57 MyVax 57 leukotriene receptor antagonist 57 NSCLC 57 GRNVAC1 57 irinotecan chemotherapy 57 camptothecin 57 EGFR expressing 57 LHRH 57 noninfectious uveitis 57 trans retinoic acid 57 TRISENOX 57 Omnitarg 57 Mitoxantrone 57 Clofarabine 57 Onrigin 57 L asparaginase 57 Camptosar ® 57 radiation sensitizer 57 riociguat 57 ethambutol 57 BrachySil 57 fenofibric acid 57 ZK EPO 57 IgG1 monoclonal antibody 57 ritonavir boosted lopinavir 57 generation purine nucleoside 57 Fodosine 57 NKTR 57 Hsp# inhibitor 57 caspofungin 57 Azedra 57 macrolide antibiotics 57 IMA# 57 cephalosporin antibiotics 57 prostone 57 Maraviroc 57 surrogate endpoint 57 Orally administered 57 anti angiogenic agent 57 factor Xa inhibitor 57 FOLFIRINOX 57 dacetuzumab 57 refractory chronic lymphocytic 57 thrombopoietin 57 dosing cohort 57 anti androgen 57 nucleotide analog 57 oral ridaforolimus 57 #ME# 57 Campath alemtuzumab 57 direct thrombin inhibitors 57 lamivudine 3TC 57 Nanobodies 57 Archexin 57 nilotinib Tasigna ® 57 Sym# 57 peginterferon alpha 2a 57 metastatic HRPC 57 TNF inhibitors 57 pyrazinamide 57 Vaprisol 57 selective androgen receptor modulator 57 antisense drug 57 metastatic kidney 57 Caelyx 57 Xelox 57 Cloretazine R VNP#M 57 LHRH antagonist 57 acting muscarinic antagonist 57 CYT# potent vascular disrupting 57 TNF inhibitor 57 microtubule targeting 57 Vilazodone 57 Sudhir Agrawal D.Phil 57 Gemzar gemcitabine 57 temsirolimus Torisel ® 57 RSD# 57 L BLP# 57 KRAS wild 57 G CSF 57 acyclovir Lauriad R 57 injected subcutaneously 57 favorable pharmacokinetic profile 57 BCR ABL inhibitors 57 Ontak 57 disease modifying antirheumatic 57 pediatric acute lymphoblastic 57 Degarelix 57 XmAb# 57 REOLYSIN ® 57 phase IIb clinical 57 DMARD 57 DsiRNA 57 pegylated interferon 57 FTY# 57 darinaparsin ZIO 57 Phase Ib study 57 interferon gamma 1b 57 olaparib 57 cangrelor 57 #mg/m# [001] 57 CTA# Injection 57 bicalutamide 57 generation cephalosporin 57 Zysolin TM 57 Roche Xeloda 57 ARIKACE 57 interferon alfa 2b 57 levodopa carbidopa 57 systemic ALCL 57 bevirimat 57 orally administered inhibitor 57 sorafenib Nexavar R 57 Octreotide 57 melphalan 57 stavudine 57 metastatic GIST 57 topical ophthalmic 57 Genz # 57 xenograft models 57 NRTI backbone 57 Nilotinib 57 RAPAFLO 57 bexarotene 57 erythropoietic 57 pegylated alpha interferon 57 tubulin binding 57 azoles 57 huN# DM1 57 intravenously administered 57 monoclonal antibody 57 Pegasys ® 57 PD LID 57 Genentech Rituxan 57 Taxotere chemotherapy 57 ATL# [001] 57 DMARDs 57 galiximab 57 Myocet 57 TLR9 agonists 57 INTEGRILIN 57 basiliximab 57 anticancer drugs 57 DXL# 57 peripherally acting 57 oral Xeloda 57 Vfend 57 LymphoStat B 57 tolvaptan 57 Azixa 57 GSK# [001] 57 orally dosed 57 Genasense 57 IgG1 antibody 57 Pegintron 57 leukemia AML 57 triptan 57 steroid dexamethasone 57 echinocandin 57 PEG interferon 57 anti CD3 antibody 57 leukemia CLL 57 Debio 57 pentamidine 57 interferon IFN 57 clotrimazole 57 YONDELIS R 57 chronic myeloid leukemia CML 57 fibrinolytic 57 HER2 negative 57 Oral NKTR 57 pamidronate 57 Davanat 57 Gemzar 57 IFN beta 57 signal transduction inhibitor 57 NVA# 57 Iressa gefitinib 57 R sorafenib tablets 57 gastrointestinal stromal tumors GIST 57 celgosivir 57 refractory cutaneous T 57 CIMZIA TM 57 MabThera Rituxan 57 RNAi therapeutic targeting 57 Apaziquone 57 retapamulin 57 chemotherapy FOLFOX 57 VNP#M 56 Clolar ® 56 Cetuximab Erbitux 56 VELCADE melphalan 56 RDEA# 56 maximally tolerated dose 56 methotrexate 56 evaluating Xcytrin 56 Tarceva 56 TAXOTERE ® 56 MYDICAR ® 56 Arixtra 56 verteporfin 56 alpha folate receptor 56 cephalosporins 56 pazopanib 56 Filgrastim 56 antithrombotics 56 sevelamer hydrochloride 56 Alimta 56 Folfox 56 pharmacodynamic properties 56 relapsed MM 56 chemotherapy regimen 56 amikacin 56 subcutaneously injected 56 Ixabepilone 56 HuMax CD# 56 μg dose 56 Rebif ® 56 zalutumumab 56 potentially hepatotoxic 56 tezampanel 56 abiraterone 56 AMPK activators 56 Nexavar 56 synthetic peptide 56 fusion inhibitor 56 CINOD 56 dose dexamethasone 56 Virulizin ® 56 Arranon 56 ELND# 56 Omacetaxine mepesuccinate 56 chronic HCV